Five-year survival comparison of different treatment modalities for muscle invasive urothelial carcinoma, squamous cell carcinoma and adenocarcinoma of the bladder: An analysis of the National Cancer Database.

Authors

null

Carlos Rivera

Cleveland Clinic Florida, Weston, FL

Carlos Rivera , Iktej Singh Jabbal , Marita Yaghi , Kevin Scott Landau , Nicolas Muruve , Diana Saravia , Tiffany L. George , Zeina A. Nahleh , Rafael Arteta-Bulos

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Other

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 575)

DOI

10.1200/JCO.2022.40.6_suppl.575

Abstract #

575

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2019 Gastrointestinal Cancers Symposium

Predictors of survival in pancreatic squamous cell carcinoma (PSCC): An analysis from the National Cancer Database (NCDB).

Predictors of survival in pancreatic squamous cell carcinoma (PSCC): An analysis from the National Cancer Database (NCDB).

First Author: Anuhya Kommalapati

Poster

2023 ASCO Annual Meeting

<span>A 19-protein signature to predict outcomes in a cohort of stage II and III CRC.</span>

A 19-protein signature to predict outcomes in a cohort of stage II and III CRC.

First Author: Rosemary Habib

First Author: Philipp Karschnia